Evidence map›Paper›PMID 40053164›Full record

ArticleMolecular biology reports2025

FTO-mediated Nrf2 demethylation alleviates high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells.

Quan Cheng, Liqiong Zhou, Xinyu Fan, Minjun Ma, Chunhui Zhang, Xu Zha, Yuanping Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. FTO-modulated mJournal of translational medicine · 2026
    Article
  4. The Effect and Molecular Mechanism ofCurrent issues in molecular biology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. The latest progression of N6-methyladenosine (mFrontiers in endocrinology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Quan Cheng *Ophthalmology Department, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmian Avenue, Wuhua District, Kunming, Yunnan, 650000, China.
Liqiong Zhou *Ophthalmology Department, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmian Avenue, Wuhua District, Kunming, Yunnan, 650000, China.
Xinyu Fan *Ophthalmology Department, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmian Avenue, Wuhua District, Kunming, Yunnan, 650000, China.
Minjun MaOphthalmology Department, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmian Avenue, Wuhua District, Kunming, Yunnan, 650000, China.
Chunhui ZhangOphthalmology Department, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmian Avenue, Wuhua District, Kunming, Yunnan, 650000, China.
Xu ZhaOphthalmology Department, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmian Avenue, Wuhua District, Kunming, Yunnan, 650000, China. chaxu@kmmu.edu.cn.ORCID http://orcid.org/0000-0002-6327-3925
Yuanping ZhangOphthalmology Department, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dianmian Avenue, Wuhua District, Kunming, Yunnan, 650000, China. zzyp1019@163.com.ORCID http://orcid.org/0000-0001-7250-963X

Funding

National Natural Science Foundation of China 81860173Scientific and technological talents and platform plan 202105AF150021
6 · The paper itself

Abstract

backgroundN6-methyladenosine (m6A) modification contributes to the development of diabetic retinopathy (DR). This study aimed to reveal the role and downstream regulatory signaling of an m6A demethylase fat mass and obesity-associated gene (FTO) in high glucose-induced damage of retinal pigment epithelial cells. METHODS AND

resultsBy stimulating ARPE-19 cells with different concentrations of glucose (0 mM-50 mM), we observed that FTO expression was significantly downregulated, while m6A modification level was upregulated in a glucose concentration-dependent manner in ARPE-19 cells. Then, ARPE-19 cells were transfected with FTO knockdown or overexpression vector, and administrated with high glucose (25mM) to perform functional verification experiments. FTO overexpression recovered cell viability, inhibited cell apoptosis, elevated GSH/GSSG ratio, but reduced MDA and ROS levels in high glucose-induced cells, while FTO knockdown further exacerbated high glucose-triggered oxidative stress and apoptotic cell death. Additionally, FTO overexpression upregulated the expression of NF-E2-related factor 2 (Nrf2) and activated the antioxidant heme oxygenase 1 (HO-1) signal through m6A demethylation on Nrf2 in high glucose-treated ARPE-19 cells. Finally, we proved that knockdown of Nrf2 or HO-1 reversed the protective effects of FTO overexpression on high glucose-treated ARPE-19 cells.

conclusionAltogether, the study demonstrated that FTO ameliorates high glucose-triggered oxidative stress and cell apoptosis through activating the Nrf2/HO-1 signaling pathway in an m6A-dependent manner.

Indexed as

Alpha-Ketoglutarate-Dependent Dioxygenase FTOGlucoseNF-E2-Related Factor 2Oxidative StressRetinal Pigment EpitheliumAdenosineApoptosisCell LineCell SurvivalDemethylationDiabetic RetinopathyEpithelial CellsHeme Oxygenase-1HumansReactive Oxygen SpeciesSignal TransductionAdenosineAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanGlucoseHeme Oxygenase-1NFE2L2 protein, humanNF-E2-Related Factor 2N-methyladenosineReactive Oxygen SpeciesDiabetic retinopathyFat mass and obesity-associated geneHeme Oxygenase 1N6-methyladenosineNF-E2-related factor 2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.